AtaGenix Laboratories Co., Ltd.
Biotechnology and laboratory services · Wuhan, Hubei
About AtaGenix Laboratories Co., Ltd.
AtaGenix Laboratories Co., Ltd. is a contract research organisation (CRO) founded in 2011 in the Wuhan National Bio-Industry Base (Optics Valley), Hubei. According to its official website it operates the designated Antibody Discovery and Screening Public Service Platform, with a 4,700 m² facility that includes a GMP-grade cell culture room and a sterile, endotoxin-free purification laboratory.
Its services rest on three integrated platforms: a life sciences platform with five protein expression systems — mammalian (HEK293/CHO), E. coli, Bacillus subtilis, yeast and insect cells — for recombinant protein production; an antibody drug discovery platform using single B cell (Xten Mab), hybridoma and phage display technologies, with proprietary VHH nanobody and naïve libraries; and a diagnostic materials platform developing antigen and antibody pairs for immunoassay kits.
Beyond services, AtaGenix markets a catalogue of more than 35,000 products under its abinScience reagent brand, covering recombinant antibodies, proteins, ELISA kits, research biosimilars, enzymes and stable cell lines. It works with pharmaceutical companies, diagnostics firms and academic centres in Asia, Europe and North America, and reports thousands of completed protein expression and antibody projects.
Its services rest on three integrated platforms: a life sciences platform with five protein expression systems — mammalian (HEK293/CHO), E. coli, Bacillus subtilis, yeast and insect cells — for recombinant protein production; an antibody drug discovery platform using single B cell (Xten Mab), hybridoma and phage display technologies, with proprietary VHH nanobody and naïve libraries; and a diagnostic materials platform developing antigen and antibody pairs for immunoassay kits.
Beyond services, AtaGenix markets a catalogue of more than 35,000 products under its abinScience reagent brand, covering recombinant antibodies, proteins, ELISA kits, research biosimilars, enzymes and stable cell lines. It works with pharmaceutical companies, diagnostics firms and academic centres in Asia, Europe and North America, and reports thousands of completed protein expression and antibody projects.